x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Foundation Fighting Blindness

Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

science

All Episodes

00:03:52

Phase 3 Clinical Trial of NAC Launched for RP Patients

Foundation Fighting Blindness ·

2024/04/12

The drug is thought to work independent of the mutated gene causing RP.

en

00:02:30

ViGeneron Launches Clinical Trial of Gene Therapy for...

Foundation Fighting Blindness ·

2024/04/11

The gene therapy is administered using a less-invasive intravitreal injection.

en

00:02:52

Ocugen to Launch Phase 3 Clinical Trial of Modifier...

Foundation Fighting Blindness ·

2024/04/08

The emerging treatment is designed to work independent of the patient’s mutated gene.

en

00:03:50

Nanoscope Plans to Apply for FDA Approval for its...

Foundation Fighting Blindness ·

2024/03/27

The company reported positive two-year results for its Phase 2 clinical trial of MCO-010.

en

00:02:58

Opus Reports Vision Improvements for Patients in LCA5...

Foundation Fighting Blindness ·

2024/03/26

Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial by Foundation Fighting Blindness

en

00:15:58

Eye on the Cure Podcast | Episode 63: Dr. Hema Ramkumar

Foundation Fighting Blindness ·

2024/03/08

Hema Ramkumar, MD, a retinal specialist, surgeon, and founder of the company Oculogenex, talks with host Ben Shaberman about her emerging therapy that targets mitchondria to slow the progression of intermediate dry age-related macular degeneration and potentially other retinal diseases. She also discusses her experiment that will put mice in space so researchers can gain a better understanding of retinal degeneration.

en

00:30:23

Eye on the Cure Podcast | Episode 62: Dr. Peter Quinn

Foundation Fighting Blindness ·

2024/02/23

Peter Quinn, PhD, a principal investigator and associate research scientist at Columbia University, talks to host Ben Shaberman about the promise of emerging CRISPR/Cas9 gene editing therapies, including base and prime editing approaches, for inherited retinal diseases. Dr. Quinn also reviews gene editing projects ongoing in his lab for patients with mutations in CRB1 and PRPH2.

en

00:02:02

jCyte Announces Plans to Launch Phase 3 Clinical...

Foundation Fighting Blindness ·

2024/02/21

Known as retinal progenitors, the company’s jCells® are designed to preserve photoreceptors in people with retinitis pigmentosa (RP) and other retinal diseases.

en

00:03:09

Beacon Therapeutics Reports Encouraging Interim...

Foundation Fighting Blindness ·

2024/02/09

Beacon Therapeutics has reported vision improvements for five of eight patients receiving the high dose of its X-linked retinitis pigmentosa (XLRP) gene therapy in the Phase 2 SKYLINE clinical trial. Known as AGTC-501, the emerging gene therapy is for patients with mutations in RPGR, the gene most frequently associated with XLRP. Interim, 12-month results for SKYLINE were reported on February 7, 2024, by Mark Pennesi, MD, PhD, director, Ophthalmic Genetics at the Retina Foundation of the Southwest,

en

00:24:34

Eye on the Cure Podcast | Episode 61: Dr. Jose Sahel

Foundation Fighting Blindness ·

2024/02/02

Dr. Jose Sahel, one of the most honored and accomplished leaders in the retinal disease research space, talks with host Ben Shaberman about his establishment and leadership of renowned ophthalmology clinical research centers at the University of Pittsburgh Medical Center and Institut de la Vision in Paris. They also discuss emerging inhertied retinal disease therapies from SparingVision, a biotech co-founded by Dr. Sahel.

en

00:03:29

Ascidian to Launch Clinical Trial for Stargardt...

Foundation Fighting Blindness ·

2024/02/01

ACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.

en

00:40:21

Eye on the Cure Podcast | Episode 60: Justin Kauflin

Foundation Fighting Blindness ·

2024/01/19

Justin Kauflin, a renowned jazz pianist who lost his vision as a boy, talks to host Ben Shaberman about his extensive touring, numerous collaborations, and close friendship with legendary trumpeter Clark Terry. Their story was captured in the hit documentary film Keep On Keepin' On. Justin became a jazz pro at the age of 14, toured globally with Quincy Jones, and was voted jazz artist of the year by VEER magazine.

en

00:25:42

Eye on the Cure Podcast | Episode 59: Dr. Robert...

Foundation Fighting Blindness ·

2024/01/05

Dr. Robert MacLaren, a world-renowned retinal surgeon, clinical trial investigator, and research lab leader at the University of Oxford, talks to host Ben Shaberman about the successes and challenges in retinal gene therapy development and clinical trials, as well as advances in robotics for improving retinal surgery outcomes.

en

00:41:29

Eye on the Cure Podcast | Episode 58: Jason Comander,...

Foundation Fighting Blindness ·

2023/12/15

Jason Comander, MD, PhD, clinical researcher, surgeon, and director of the Inherited Retinal Disease Disorders Service at Mass Eye and Ear, talks to host Ben Shaberman about his administration of LUXTURNA gene therapy to RPE65 patients, his team's re-analysis of vitamin A therapy for retinitis pigmentosa, and passion for retinal research and patient care.

en

00:03:44

Théa Completes Acquisition of ProQR’s LCA10 and USH2A...

Foundation Fighting Blindness ·

2023/12/11

Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials

en

00:39:48

Eye on the Cure Podcast | Episode 57: James Rath

Foundation Fighting Blindness ·

2023/12/01

James Rath, a renowned filmmaker and accessibility consultant, talks to host Ben Shaberman about his vision loss journey and travel documentary, Blindspots. The new streaming program, on CuriosityStream.com, follows James as he explores the globe in search of accessible adventures, remarkable blind personalities, and great food.

en

00:31:38

Eye on the Cure Podcast | Episode 56: Michael...

Foundation Fighting Blindness ·

2023/11/10

Michael Voevodsky, MBA, CEO at MitoChem Therapeutics, talks to host Ben Shaberman about his company's emerging, gene-agnostic treatment designed to boost mitochondrial function for preserving vision in people with retinitis pigmentosa, age-related macular degeneration, and other retinal conditions.

en

00:04:21

Kiora Reports Vision Restoration in Phase 1/2...

Foundation Fighting Blindness ·

2023/11/08

The company’s molecule is designed to restore some vision to people with ultra-low or no vision caused by advanced retinitis pigmentosa and other retinal diseases.

en

00:05:44

New Report: Vitamin A Supplementation Provides No...

Foundation Fighting Blindness ·

2023/11/02

The report also concludes that vitamin E supplementation accelerates vision loss for RP patients.

en

00:25:41

Eye on the Cure Podcast | Episode 55: Omar Mahroo,...

Foundation Fighting Blindness ·

2023/10/13

Omar Mahroo, MB, PhD, talks with host Ben Shaberman about electrophysiological testing for the retina, namely the electroretinogram (ERG), and its important role in evaluating and diagnosing inherited retinal diseases. Dr. Mahroo is a consultant ophthalmologist and retinal specialist at Moorfields Eye Hospital and St. Thomas’ Hospital in London, and Professor of Retinal Neuroscience at University College London.

en

255 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter